Navigation Links
Mild Sadness Provokes Depressive Thinking in Some Recovered Patients

Some individuals with a history of depression may sink back into thinking patterns associated with the condition when faced with mild stresses or sadness//, increasing their risk for relapse.

Many patients who recover from depression eventually relapse, according to background information in the article. Management of depression usually focuses on alleviating symptoms rather than reducing the risk for recurrence or identifying patients who might relapse after successful treatment. Previous studies have found that some patients who have recovered from depression still show cognitive processes—patterns in thinking, learning and memory—commonly associated with the condition, while others in remission do not. Such cognitive processes include certain ways of explaining events or particular assumptions about self-worth.

Zindel V. Segal, Ph.D., University of Toronto and Centre for Addiction and Mental Health, Ontario, and colleagues randomly assigned 301 patients with major depressive disorder to receive either antidepressant medications or cognitive behavioral therapy (a kind of psychotherapy designed to modify the cognitive processes that are typically associated with depression). Ninety-nine of those whose depression went into remission participated in a second phase of the trial. These 99 participants rated their current mood on a visual scale from sad to happy and underwent an assessment of their dysfunctional attitudes, signs of the cognitive processes that are associated with depression. The researchers then provoked a sad mood by asking participants to listen to a piece of music and try to recall a time in their lives when they felt sad. After this exercise, the participants rated their mood and underwent the dysfunctional attitude assessment a second time and were observed bimonthly for the next 18 months.

Seventy-eight patients completed the full 18 months of follow-up; 47.5 percent of those who had recovered through antidepres
'"/>




Page: 1 2

Related medicine news :

1. Depressive Mothers Do Not Play Enough With Their Infants
2. Sertraline Can Prevent Recurrent Depressive Episodes In Diabetics
3. Inculcating Positive Thoughts Could Eliminate Depressive Mood
4. Positive Thinking
5. Thinking Could Be Affected Due To Hormone Therapy
6. Amnesia Halts Future Thinking: Study
7. Uric Acid Levels Tied to Impaired Thinking in the Elderly
8. Positive Thinking Helps to Ward Off Depression
9. British man Recovered from HIV
10. More Bones of Aborted Fetuses Recovered from Hospital Premises
11. One in Three Heart Attack Patients Have No Chest Pains
Post Your Comments:
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Qforma Appoints Erin McLaughlin as Director Field Operations 5834 1Qforma Appoints Erin McLaughlin as Director Field Operations 5834 2Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 1Webcast Alert 3A Transgenomic Inc Announces Third Quarter 2009 Earnings Release Conference Call Webcast 5832 2High Resolution Breast PET Improves Breast Cancer Detection 5830 1High Resolution Breast PET Improves Breast Cancer Detection 5830 2High Resolution Breast PET Improves Breast Cancer Detection 5830 3